Nirsevimab, sold under the brand name Beyfortus, is a human recombinant monoclonal antibody with activity against respiratory syncytial virus (RSV). It...

GSK plc) and Abrysvo (Pfizer). The prophylactic use of palivizumab or nirsevimab (both are monoclonal antibody treatments) can prevent RSV infection in...

Merck, it is in a phase III trial as of 2023. It works differently than nirsevimab. Odumade, Oludare A; van Haren, Simon D; Angelidou, Asimenia (15 August...

them due to the clear benefit that they have shown in clinical trials. Nirsevimab, a monoclonal antibody against RSV, is approved by the FDA for all children...

development of vaccines and antiviral therapies against RSV infections. Nirsevimab, an approved medication, whole human monoclonal antibody against F protein...

Sotrovimab J06BD06 Regdanvimab J06BD07 Casirivimab and imdevimab J06BD08 Nirsevimab J06BD09 Sipavibart Immune sera and immunoglobulins for veterinary use...

has also laid the groundwork for multiple patented therapies, including Nirsevimab, originally discovered by cell biologist Hergen Spits. Amsterdam UMC's...

benralizumab (anti-IL-5R) tralokinumab (anti-IL-13) anifrolumab (anti-IFN-aR) nirsevimab (anti-RSV) MedImmune, Inc. v. Genentech, Inc. "12 years on, Astra draws...

Neonatal fragment crystallizable receptor Y generalized myasthenia gravis Nirsevimab Beyfortus human RSV fusion glycoprotein respiratory syncytial virus Nivolumab...

Stadium in Inglewood, California. July 17 – The FDA approves the drug Nirsevimab, also known as Beyfortus, which treats RSV in infants. July 18 – Michigan...

Exbivirumab§ Foravirumab§ Imdevimab† (+casirivimab) Libivirumab§ Maftivimab Nirsevimab† Odesivimab Pemivibart Rafivirumab§ Regavirumab§ Regdanvimab Sevirumab†...